Diabetes

Semaglutide significantly improves liver inflammation and fibrosis in MASH patients, offering new hope for clinical management.

Low-energy diets are safe in pregnancy with gestational diabetes but show no clinical benefit in weight or birth weight.

Read about how vitamin supplementation does not significantly influence the development or progression of Type 1 diabetes.

Switching to tirzepatide yields greater HbA1c and weight reductions than escalating dulaglutide in Type 2 diabetes.

Elevated triglycerides in well-controlled gestational diabetes linked to increased pregnancy risks, suggesting lipid monitoring may be crucial.

Mind-body exercises show promising benefits for type 2 diabetes, improving blood sugar, weight, and heart health markers.

Higher eGDR linked with lower mortality and cardiovascular risk in diabetes, offering promise for clinical risk stratification.

Newer diabetes drugs linked to reduced risk of dementia in older adults, real-world data shows promising results.